Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
June 15, 2021
Patent Application Number
16185960
Date Filed
November 9, 2018
Patent Citations Received
Patent Primary Examiner
Patent abstract
Therapeutic combinations of immunoconjugates that bind to FOLR1 (e.g., IMGN853) with anti-VEGF agents (e.g., bevacizumab), a platinum-based agent, and/or doxorubicin are provided. Methods of administering the combinations to treat cancers, e.g., ovarian cancers, with greater clinical efficacy and/or decreased toxicity are also provided.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
